Crovalimab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Crovalimab. Educational only — not medical advice.
Labeled uses
PIASKY is indicated for the treatment of adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg.
Source: FDA labeling via NIH DailyMed (set 2597efc2…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.